Knockout of the peroxiredoxin 5 homologue PFAOP does not affect the artemisinin susceptibility of Plasmodium falciparum
Abstract Artemisinins are the current mainstay of malaria chemotherapy. Their exact mode of action is an ongoing matter of debate, and several factors have recently been reported to affect an early stage of artemisinin resistance of the most important human malaria parasite Plasmodium falciparum. He...
Guardado en:
Autores principales: | Carine F. Djuika, Verena Staudacher, Cecilia P. Sanchez, Michael Lanzer, Marcel Deponte |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/80aec3c117b048aab371a5c43075b7a3 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Protein abundance and folding rather than the redox state of Kelch13 determine the artemisinin susceptibility of Plasmodium falciparum
por: Robin Schumann, et al.
Publicado: (2021) -
Globally prevalent PfMDR1 mutations modulate Plasmodium falciparum susceptibility to artemisinin-based combination therapies
por: M. Isabel Veiga, et al.
Publicado: (2016) -
Prevalence of potential mediators of artemisinin resistance in African isolates of Plasmodium falciparum
por: Afolabi Owoloye, et al.
Publicado: (2021) -
Absence of Plasmodium falciparum artemisinin resistance gene mutations eleven years after the adoption of artemisinin-based combination therapy in Nigeria
por: Moses Ikegbunam, et al.
Publicado: (2021) -
Restructured Mitochondrial-Nuclear Interaction in Plasmodium falciparum Dormancy and Persister Survival after Artemisinin Exposure
por: Sean V. Connelly, et al.
Publicado: (2021)